References

Sources

• This article uses information from a public domain U.S. National Cancer Institute fact sheet.

[edit]Notes

1. ^ "Mesothelioma risks and causes : Cancer Research UK : CancerHelp UK". Cancerhelp.org.uk. 2010-06-23. Retrieved 2010-08-20.


2. ^ Ashrafian H, Athanasiou T, Yap J, DeSouza AC. Two-chamber intracardiac mesothelioma. Asian Cardiovasc Thorac Ann. 2005 Jun;13(2):184-6.


3. ^ Eastbourne Today. "Woman's death from asbestos". Retrieved 2008-10-28.


4. ^ Muscat JE, Wynder EL (May 1991). "Cigarette smoking, asbestos exposure, and malignant mesothelioma". Cancer Res. 51 (9): 2263–7. PMID 2015590.


5. ^ EBSCO database verified by URAC; accessed from Mount Sinai Hospital, New York


6. ^ ^{a b c d e} Roggli VL, Sharma A, Butnor KJ, Sporn T, Vollmer RT (2002). "Malignant mesothelioma and occupational exposure to asbestos: a clinicopathological correlation of 1445 cases". Ultrastruct Pathol 26(2): 55–65. doi:10.1080/01913120252959227. PMID 12036093.


7. ^ Sporn TA and Roggli VL: Mesothelioma. In: Pathology of Asbestos-associated Diseases, Second Edition (VL Roggli, TD Oury and TA Sporn, eds.), Springer 2004,pp104


8. ^ Gennaro V et al. (2000). "Mesothelioma and Lung Tumors Attributable to Asbestos among Petroleum Workers". Am J Ind Med 37: 257–282.


9. ^ Selikoff IJ: Occupational Respiratory Diseases. In: Public Health and Preventative Medicine, Twelfth Edition (Last J ed.), Appleton-Century-Crofts, 1986, pp. 532


10. ^ Henderson DW et al. (2004). "After Helsinki: A multidisciplinary review of the relationship between asbestos exposure and lung cancer, with emphasis on studies published during 1997-2004". Pathology 36(6): 517–550. doi:10.1080/00313020400010955. PMID 15841689.


11. ^ MacLachlan DS (2002). "SV40 in human tumors: new documents shed light on the apparent controversy". Anticancer Res 22 (6B): 3495–9. PMID 12552945.


12. ^ NIOSH Working Group Paper from the Centers for Disease Control, 1980


13. ^ Hillerdal G. Mesothelioma: Cases Associated with Non-occupational and Low Dose Exposures. Occup Environ Med, 1999;56:505-513


14. ^ ^a b Peto J, Seidman H and Selikoff IJ. Mesothelioma Mortality in Asbestos Workers: Implications for Models of Carcinogenesis and Risk Assessment. Brit J Cancer, 1982;45:124-135


15. ^ Burdorf A, Dahhan M, Swuste P (2003). "Occupational characteristics of cases with asbestos-related diseases in The Netherlands". Ann Occup Hyg 47 (6): 485–92. doi:10.1093/annhyg/meg062.PMID 12890657.


16. ^ "Hygiene standards for airborne amosite asbestos dust. British Occupational Hygiene Society Committee on Hygiene Standards". Ann Occup Hyg 16 (1): 1–5. 1973. PMID 4775386.


17. ^ Lanphear BP and Buncher CR. Latent Period for Malignant Mesothelioma of Occupational Origin. J Occup Med, 1992;4:718-721


18. ^ Dogan, Umran (2003). "Mesothelioma in Cappadocian villages". Indoor and Built Environment(Ankara: Sage) 12 (6): 367–375. doi:10.1177/1420326X03039065. ISSN: 1420-326X. Retrieved 2008-03-04.


19. ^ Carbone, Michelle; et al. (2007). "A mesothelioma epidemic in Cappadocia: scientific developments and unexpected social outcomes". Nature Reviews Cancer 7 (2): 147–54. doi:10.1038/nrc2068.PMID 17251920. ISSN 1474-175X. Retrieved 2008-03-04.


20. ^ Protecting Workers' Families: A Research Agenda. National Institute for Occupational Safety and Health. DHHS (NIOSH) Publication No. 2002-113.


21. ^ Radiographic Abnormalities and Exposure to Asbestos-Contaminated Vermiculite in the Community of Libby, Montana, USA


22. ^ Edwards JG, Abrams KR, Leverment JN et al. (2000). "Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic systems". Thorax 55 (9): 731–735.doi:10.1136/thorax.55.9.731. PMC 1745842. PMID 10950889.


23. ^ ^a b Ceresoli, GL, , Santoro A (July 2007). "Multidisciplinary treatment of malignant pleural mesothelioma". Oncologist 12 (7): 850–863. doi:10.1634/theoncologist.12-7-850.PMID 17673616.


24. ^ Rusch, VW (October 1995). "A proposed new international TNM staging system for malignant pleural mesothelioma". Chest 12 (7): 895–897. PMID 7555126.


25. ^ Robinson BW, Creaney J, Lake R et al. (July 2005). "Soluble mesothelin-related protein—a blood test for mesothelioma". Lung Cancer 49 Suppl 1: S109–11. doi:10.1016/j.lungcan.2005.03.020.PMID 15950789.


26. ^ Beyer, HL, , Glover CL et al. (April 2007). "MESOMARK: a potential test for malignant pleural mesothelioma". Clinical Chemistry 53 (4): 666–672. doi:10.1373/clinchem.2006.079327.PMID 17289801.


27. ^ "The Junkman's Answer to Terrorism: Use More Asbestos | Center for Media and Democracy". Prwatch.org. Retrieved 2010-08-20.


28. ^ ^a b c Borasio P, Berruti A, Bille A, et al. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients. Eur J Card Thor Surg 2008;33:307-313


29. ^ Haber SE and Haber JM. Malignant Mesothelioma: A Clinical Study of 238 Cases. Ind Health, 2011;49:166-172


30. ^ Vogelzang N, Rusthoven J, Symanowski J, Denham C, Kaukel E, Ruffie P, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003 Jul;21(14):2636-44


31. ^ Santoro A, O'Brien M, Stahel R, Nackaerts K, Baas P, Karthaus M, et al. Pemetrexed plus cisplatin or pemetrexed plus carboplatin for chemonaïve patients with malignant pleural mesothelioma: results of the International Expanded Access Program. J Thorac Oncol. 2008 Jul;3(7):756-63.


32. ^ Sugarbaker PH, Welch LS, Mohamed F, Glehen O (July 2003). "A review of peritoneal mesothelioma at the Washington Cancer Institute". Surg Oncol Clin N Am 12 (3): 605–21, xi. doi:10.1016/S1055-3207(03)00045-0. PMID 14567020.
    Online manual: Management of Peritoneal Surface Malignancy.


33. ^ Richards WG, Zellos L, Bueno R, Jaklitsch MT, Janne PA, Chirieac LR, Sugarbaker DJ (July 2006). "Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma.". J Clin Oncol. 24 (10): 1561–7. doi:10.1016/S1055-3207(03)00045-0.PMID 14567020.


34. ^ Sugarbaker DJ, Flores RM, Jaklitsch MT et al. (January 1999). "Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients". J Thorac Cardiovasc Surg 117 (1): 54–63; discussion 63–5. doi:10.1016/S0022-5223(99)70469-1. PMID 9869758.


35. ^ Pass HI, Temeck BK, Kranda K et al. (1998). "Preoperative tumor volume is associated with outcome in malignant pleural mesothelioma.". J Thorac Cardiovasc Surg 115: 310–7; discussion 317–8.doi:10.1016/S0022-5223(98)70274-0. PMID 9475525.


36. ^ Sugarbaker, DJ (2006). "Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma". J Thorac Oncol 1 (2): 175–176. doi:10.1097/01243894-200602000-00014. PMID 17409850.


37. ^ Sugarbaker DJ, Jaklitsch MT, Bueno R et al. (2004). "Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies.". J Thorac Cardiovasc Surg 128 (1): 138–146. doi:10.1016/j.jtcvs.2004.02.021. PMID 15224033.


38. ^ Bianchi, C; Bianchi T (June 2007). "Malignant mesothelioma: global incidence and relationship with asbestos". Industrial Health 45 (3): 379–387. doi:10.2486/indhealth.45.379. PMID 17634686.


39. ^ Robinson BW, Lake RA (October 2005). "Advances in malignant mesothelioma". The New England Journal of Medicine 353 (15): 1591–603. doi:10.1056/NEJMra050152. PMID 16221782.


40. ^ "DB-397.0.REPORT.JN.ppt" (PDF). Retrieved 2010-08-20.


41. ^ Lerner, Barron H. (2005-11-15). "McQueen's Legacy of Laetrile". New York Times. Retrieved May 12, 2010.


42. ^ RTE radio 1, Playback, 8 December


43. ^ u.tv


44. ^ Irish singer Hennessy dies at 62 - BBC News - 11 December 2007


45. ^ MP MacDougall dies after illness - BBC NEWS


46. ^ Gould, Stephen Jay. "The Median Isn't the Message".


47. ^ Kraus, Paul. "Surviving Mesothelioma and Other Cancers: A Patient's Guide".


48. ^ ORTIZ V. FIBREBOARD CORP. (97-1704) 527 U.S. 815 (1999) had individual liability from a single corporation and its insurance carriers of nearly $2 billion.


49. ^ ORTIZ V. FIBREBOARD CORP. (97-1704) 527 U.S. 815 (1999)


50. ^ Wagner JC, Sleggs CA, Marchand P (October 1960). "Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province". Br J Ind Med. 17: 260–71. PMC 1038078.PMID 13782506.


51. ^ Alastair J Moore, Robert J Parker, John Wiggins (2008). "Malignant mesothelioma". Orphanet Journal of Rare Diseases 3 (34): 1750–1172. doi:10.1186/1750-1172-3-34. PMC 2652430.PMID 19099560.


52. ^ McNulty JC (December 1962). "Malignant pleural mesothelioma in an asbestos worker". Med J Aust 49(2): 953–4. PMID 13932248.


53. ^ "June Hancock Research Fund". Retrieved 2010-03-01.